Sampayan, Rochelle D.

HRN: 21-80-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
CEFUROXIME 1.5GM (VIAL)
09/08/2022
09/10/2022
IV
1.5g Then 750
Q8 Hrs
SP LTCS

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines